Advances in Management of Hepatocellular Carcinoma

Area of Science:

• Hepatology
• Oncology
• Gastroenterology

Background:

• Hepatocellular carcinoma (HCC) is a prevalent and aggressive liver cancer globally, particularly in Asia and Africa.
• Many patients are diagnosed late due to asymptomatic presentation, leading to poor prognoses.
• Established risk factors include chronic hepatitis B/C virus infections, alcoholic cirrhosis, and nonalcoholic steatohepatitis.

Purpose of the Study:

• To review current evidence-based management strategies for Hepatocellular Carcinoma (HCC).
• To focus on treatment approaches for early to advanced stages of HCC.
• To highlight management options impacting patient overall survival.

Main Methods:

• Literature review of evidence-based management of HCC.
• Analysis of treatment options based on disease stage.
• Focus on strategies influencing patient survival outcomes.

Main Results:

• The Barcelona Clinic Liver Cancer (BCLC) Staging System is the standard for HCC management.
• Treatment options are diverse, including resection, transplantation, ablation, chemoembolization, and targeted therapy (sorafenib).
• Management remains challenging due to resource limitations in many regions.

Conclusions:

• Effective HCC management requires tailored approaches based on staging and available resources.
• Early diagnosis and timely intervention are crucial for improving patient survival.
• Continued research and resource optimization are needed to address the global impact of HCC.